Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test
- PMID: 70294
- PMCID: PMC1541031
Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test
Abstract
A cytomegalovirus (CMV) induced lymphocyte tranformation test (LTT) performed as a microtechnique assay is described. Investigations were done in a group of twenty-five healthy adults with normal lymphocyte reactivity to phytohaemagglutinin and previously encountered antigens. Lymphocyte reactivity was established in CMV-seropositive persons using heat-inactivated cell-free CMV strain AD 169 in an optimal stimulating dose of 10(1-5) TCID 50. Positive CMV-LTT results were shown to be induced by purified inactivated CMV. Most persons (twelve out of seventeen) with antibodies against CMV-induced late or virus-structure antigens (LA) showed positive (stimulation index greater than 2-0) CMV-LTT results. Magnitude of CMV-LTT responses was positively related to the CMV-LA Ab titres (P less than 0-01). All persons (six) with antibodies against CMV early or non-structural antigens showed positive CMV-LTT results and highest stimulation rates were found in this group. Generally CMV-seronegative persons were non-responsive. Only in one case (LA Ab titre 10) a borderline positive response (stimulation index 2-3) was seen. The CMV-LTT was shown to have virus-specific properties because it was not related to simultaneously performed LTTs with Epstein-Barr virus and Herpes simplex virus in the same persons. It is concluded that CMV-LTTs are useful virus-specific in vitro techniques for the study of CMV-directed lymphocyte reactivity. Its possible relationship to other cell-mediated immunity tests and its practical applications are discussed.
Similar articles
-
The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence.Clin Exp Immunol. 1988 Dec;74(3):326-32. Clin Exp Immunol. 1988. PMID: 2853014 Free PMC article.
-
HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.J Immunol. 1986 Apr 15;136(8):3045-51. J Immunol. 1986. PMID: 2420881
-
Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.J Clin Lab Immunol. 1980 Nov;4(3):145-51. J Clin Lab Immunol. 1980. PMID: 6259357
-
Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.Acta Microbiol Immunol Hung. 1995;42(2):179-87. Acta Microbiol Immunol Hung. 1995. PMID: 7551711
-
Future perspectives on in-vitro diagnosis of drug allergy by the lymphocyte transformation test.J Immunol Methods. 2021 Aug;495:113072. doi: 10.1016/j.jim.2021.113072. Epub 2021 May 14. J Immunol Methods. 2021. PMID: 34000289 Review.
Cited by
-
The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence.Clin Exp Immunol. 1988 Dec;74(3):326-32. Clin Exp Immunol. 1988. PMID: 2853014 Free PMC article.
-
Blastogenic response of human lymphocytes to early antigen(s) of human cytomegalovirus.Infect Immun. 1983 Sep;41(3):1084-8. doi: 10.1128/iai.41.3.1084-1088.1983. Infect Immun. 1983. PMID: 6309659 Free PMC article.
-
Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera.J Virol. 1985 Apr;54(1):240-4. doi: 10.1128/JVI.54.1.240-244.1985. J Virol. 1985. PMID: 2983117 Free PMC article.
-
Cytomegalovirus-specific lymphocyte transformations in subjects of different ages with primary immunodeficiency.Infect Immun. 1980 Apr;28(1):49-53. doi: 10.1128/iai.28.1.49-53.1980. Infect Immun. 1980. PMID: 6155348 Free PMC article.
-
Longitudinal studies of cytomegalovirus-specific cell-mediated immunity in congenitally infected infants.Infect Immun. 1983 Jul;41(1):128-31. doi: 10.1128/iai.41.1.128-131.1983. Infect Immun. 1983. PMID: 6305837 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources